Lidamycin

力达霉素

Report date: 2025/06/25 15:49:03
NME

Base Information

Drug NameLidamycin
Drug Alias NameLDCC 1027 chromophoreAntibiotic C-1027 chromophoreC-1027
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDNA inhibitorsDNA damage modulators
TargetsDNA
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland ChinaJapan
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaClinical
Originator CompaniesTaiho Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biotechnology, Chinese Academy Of Medical Sciences
Inactive CompaniesTaiho Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksKEGG